KAZIA THERAPEUTICS
Live / Registered — Registered — Section 71 accepted (as of 09 Sept 2025)
What this means for you
Registered since 01 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79227049
- Registration number
- 5640030
- Mark type
- Stylized text
- Filed
- 26 Sept 2017
- Published for opposition
- 16 Oct 2018
- Registered
- 01 Jan 2019
- Attorney of record
- Sana Hakim
Goods and services
- Class 001 — Chemicals: Chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes
- Class 042 — Scientific and technological services: Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services
Owner
- Kazia Therapeutics Limited, Sydney NSW, AU
- Kazia Therapeutics Limited, AU
- Kazia Therapeutics Limited, AU
Prosecution history
- 09 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 09 Sept 2025 — REGISTERED-SEC.71 ACCEPTED
- 08 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 03 Jun 2025 — TEAS SECTION 71 RECEIVED
- 01 Jan 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Jun 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 03 May 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 15 Apr 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 15 Apr 2019 — FINAL DISPOSITION PROCESSED
- 01 Apr 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 15 Mar 2019 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 01 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Oct 2018 — PUBLISHED FOR OPPOSITION
- 12 Oct 2018 — NOTIFICATION PROCESSED BY IB